Stryker is making a takeover bid to acquire Boston Scientific, according to those "familiar with the matter," The Wall Street Journal reports.
Here are five things to know:
1. Boston Scientific has not commented on Stryker's takeover offer, according to CNBC.
2. The potential acquisition would combine Stryker's orthopedics, neurotechnology and spine focus with Boston Scientific's cardiovascular expertise.
3. If the deal came to fruition, the new company would be valued at more than $110 billion. Stryker currently has a value of $67 billion and Boston Scientific is valued at $44 billion.
4. Stryker reported $12.4 billion in 2017 global net sales, and Boston Scientific saw net sales of $9.05 billion the same year.
5. On Monday afternoon, Stryker's shares fell more than 4 percent and Boston Scientific's increased about 8 percent, CNBC reports.
Read more about the potential deal, here.